Exposure Therapy and Safety-seeking Behavior in Chronic Low Back Pain
Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Oct 23, 2013
Trial Information
Current as of June 23, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Suffer from chronic low back pain not caused by serious spinal injury, for at least 3 to 6 months
- • Report a sufficient level of disability (this is in itself already a criterion to start treatment at the Rehabilitation department) and
- • Moderate to high levels of pain-related fear (TSK \> 37 or at least 4 items with a score of 3 or \>3)
- • Have a partner willing to participate
- Exclusion Criteria:
- • Specific medical disorder or cardiovascular disease preventing participation in physical exercise
- • Serious psychopathologic co-morbidity. This is checked during anamnesis in the intake session with the rehabilitation physician and during the screening (standard care, see session 1 and session 2). When psychopathologic co-morbidity is detected, patients cannot participate in the study and may not be suitable candidates for exposure therapy entirely. Any decision regarding treatment recommendation is made with the entire treatment team. Furthermore, the researcher performing the therapy has a Master's degree in Clinical Psychology, which adds to the treatment team's expertise on psychopathology.
- • Alcohol or drug abuse, i.e., at least one out of the four following criteria needs to be fulfilled: continued use despite social or interpersonal problems; repeated use resulting in failure to fulfill obligations at work, school, or home; repeated use resulting in physically hazardous situations; use resulting in legal problems (according to the Diagnostic Statistical Manual of Mental disorders, 4th ed.). This is assessed by the rehabilitation physician during the first session.
- • Illiteracy
- • Pregnancy
- • Involvement in litigation concerning the patient's ability to work or disability income
- • Non-Dutch speaking
About Maastricht University Medical Center
Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maastricht, , Netherlands
Patients applied
Trial Officials
Johan Vlaeyen, PhD
Principal Investigator
Maastricht University and University of Leuven
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials